Department of veterans affairs hypertension meeting: A proposal for improved care

Hypertension

Volumn 35, Issue 4, 2000, Pages 853-857

  Perry, H Mitchell ^a   Freis, Edward D ^b   Frohlich, Edward D ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c Alton Oschner Clinic   (United States)

Author keywords

Blood pressure; Detection and control; Diuretics; Drug therapy; Hypertension; Malignant

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DILTIAZEM; DIURETIC AGENT; HYDROCHLOROTHIAZIDE;

ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0034106593     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.4.853     Document Type: Article

References (25)

1. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997;157:2413-2446.
3. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
4. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. JAMA. 1970;213:1143-1152.
5. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA. 1967;202:1028-1034.
6. Perry HM Jr, Bingham S, Homey A, Rutan G, Sambhi M, Carmody S, Collins J, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Antihypertensive efficacy of treatment regimens used in Veterans Administration Hypertension Clinics. Hypertension. 1998;31:771-779.
7. Perry HM Jr, Belton ED, Moses WG, Page IR, Smith WM, Sokolow M, Witwer BD. National High Blood Pressure Education Program: Report to the Hypertension Information and Education Advisory Committee, Task Force I Data Base. Washington, DC: US Department of Health, Education, and Welfare; 1973: publication No (NIH) 74-593.
8. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Return of elevated blood pressure after withdrawal of antihypertensive drugs. Circulation. 1975;51:1107-1113.
9. Freis ED, Thomas JT, Fisher SG, Hamburger R, Borreson RE, Mezey KC, Mukherji B, Neal WW, Perry HM, Taguchi JT, for the Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of reduction in drugs or dosage after long-term control of systemic hypertension. Am J Cardiol. 1989;63:702-708.
10. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
11. Materson BJ, Reda DJ, Cushman WC, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Department of Veterans Affairs single-drug therapy of hypertension study: revised figures and new data. Am J Hypertens. 1995;8:189-192.
12. Collins R, Peto R, MacMahon S, Hebert P, Flebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke and coronary heart disease, part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990:335:827-838.
13. Hansson L, Zanchetti, Caruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S, for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
14. Lockhart G, van Noorden G, Dustan HP, Corcoran AC, Page IH. The course of retinopathy in treated malignant hypertension. Arch Intern Med. 1960;106:205-212.
15. Miller JP, Perry HM Jr, Rossiter JE, Baty JD, Carmody SE, Sambhi MP. Regional differences in mortality during 15-year follow-up. Hypertension. 1994;23:431-438.
16. National Center for Health Statistics. Blood pressure levels in persons 6-74 years: United States, 1971-74. Vital Health Stat. 1977:11. US Dept of Health and Human Services publication (PHS) 78-1648.
17. Frohlich ED. State-of-the-art lecture: risk mechanisms in hypertensive heart disease. Hypertension. 1999;34:782-789.
18. Frohlich ED. Corcoran Lecture: influence of nitric oxide and angiotensin II on renal involvement in hypertension. Hypertension. 1997;29: 188-193.
19. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and the risk of coronary heart disease: the Framingham Study. Am J Cardiol. 1971;27:335-346.
20. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
21. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their causes and prognosis. Am J Med Sci. 1939;197:332-343.
22. Smith DE, Odell HMO, Kernohan JW. Causes of death in hypertension. Am J Med. 1950;9:516-527.
23. Frohlich ED. The necessity for recognition and treatment of patients with "mild" hypertension. J Am Coll Cardiol. 1999;34:1369-1377.
24. Perry HM, Miller JP, Baty JD, Carmody SE, Sambhi MP. Pretreatment blood pressure as a predictor of 20-year mortality. Am J Hypertens. In press.
25. Perry HM Jr, Schnaper HW, Meyer G, Swatzell R. Clinical program for screening and treatment of hypertension in veterans. J Natl Med Assoc. 1982;74:433-444.